Related Experiment Video
Updated: Jan 13, 2026
Microfluidic Chip Fabrication and Method to Detect Influenza
Published on: March 26, 2013
A Single-step Platinum Nanoparticle-Enhanced Lateral Flow Immunoassay Platform for Rapid Detection of Influenza A
Chang Woon Choi1, Kyuhan Lee1, Hyungbin Park1
1Department of Chemistry, School of Physics and Chemistry, Gwangju Institute of Science and Technology, 123 Chumdangwagiro, Buk-gu, Gwangju 61005, Republic of Korea.
Insights
A new point-of-care diagnostic platform uses platinum nanoparticles and smartphone imaging for highly sensitive influenza A virus detection. This method offers a 1000-fold increase in sensitivity over traditional tests, enabling rapid and accurate diagnoses.
Area of Science:
- Biomedical Diagnostics
- Nanotechnology in Medicine
- Point-of-Care Testing
Background:
- Lateral flow immunoassays (LFIA) are common point-of-care (POC) tools but often lack the sensitivity for reliable diagnoses.
- Influenza A virus (IAV) detection requires sensitive and rapid diagnostic methods, especially at the POC.
Purpose of the Study:
- To develop a novel, highly sensitive POC diagnostic platform for Influenza A Virus (IAV) detection.
- To integrate reagent-free signal amplification with smartphone-based quantitative analysis for improved LFIA performance.
Main Methods:
- Developed a platform using platinum nanoparticle-catalyzed TMB oxidation for signal amplification.
- Integrated a reagent-free, single-step amplification process with smartphone image acquisition and analysis.
- Utilized chromatographically delayed acidic migration for timed signal enhancement.
Main Results:
- Achieved a limit of detection of 11.6 pg/mL for IAV nucleoprotein within 15 minutes.
- Demonstrated approximately 100-fold visual signal amplification and a 1000-fold increase in sensitivity over traditional LFIAs.
- Clinical trials showed 96.8% sensitivity and 98.4% specificity compared to RT-PCR, with semiquantitative capability.
Conclusions:
- The developed platform offers a rapid, sensitive, objective, and quantitative method for IAV detection at the POC.
- Integration of catalytic signal enhancement and digital analysis overcomes limitations of conventional LFIAs.
- This user-friendly system provides an accurate and low-cost solution for viral diagnostics.
Abstract:
Lateral flow immunoassays (LFIAs) are widely used point-of-care (POC) diagnostic tools, but their limited sensitivity can hinder reliable diagnoses. To address this limitation, we developed a novel POC diagnostic platform for the highly sensitive detection of influenza A virus (IAV). This developed platform integrates platinum nanoparticle-catalyzed 3,3',5,5'-tetramethylbenzidine (TMB) oxidation for reagent-free, single-step signal amplification with smartphone-based image acquisition and quantitative analysis. This combination of catalytic enhancement and digital interpretation enables rapid, objective, and quantitative diagnostic evaluation, offering improved performance over conventional LFIAs. Upon sample application, the sample flows to complete the immunoreaction at the test line, followed by a chromatographically delayed acidic migration that rehydrates the TMB and delivers it to the captured platinum nanoparticles for signal amplification. This reagent-free, timed enhancement results in approximately 100-fold visual signal amplification compared to unenhanced detection, without the need for additional reagents. Additionally, a custom-developed smartphone application automates image acquisition and quantifies intensity ratios to provide the final diagnosis. The platform achieves a limit of detection of 11.6 pg/mL IAV nucleoprotein within 15 min, offering a 1000-fold increase in sensitivity over traditional LFIAs. In clinical trials, it demonstrated excellent performance, with 96.8% sensitivity and 98.4% specificity compared to RT-PCR. The platform also exhibited semiquantitative capability, with a strong inverse correlation (R2 = 0.832) between RT-PCR Ct values and intensity ratios. This integrated system provides a rapid, low-cost, and user-friendly solution for accurate viral diagnostics.
